Healthcare Services

Uveal Neoplasms Market Impacted by Rising Eye Cancer Incidence Driving Market Growth

April 28, 2026April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Uveal Neoplasms Market Progress Between 2026 And 2030?

The uveal neoplasms market has shown considerable expansion in recent years. Its valuation is anticipated to rise from $1.14 billion in 2025 to $1.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.7%. The surge observed in the past can be ascribed to better ophthalmic diagnostic instruments, the establishment of more specialized eye care facilities, greater public knowledge about ocular tumors, the availability of radiation-based treatments, and an increase in ophthalmic oncology proficiency.

The uveal neoplasms market is projected to experience robust expansion over the coming years. By 2030, its valuation is predicted to reach $1.5 billion, demonstrating a compound annual growth rate (CAGR) of 5.6%. This growth during the forecast period is attributable to several factors, including the increasing integration of precision medicine in ophthalmology, heightened investment in ocular oncology research, broader applications of immunotherapy, rising demand for less invasive eye procedures, and expanded utilization of advanced imaging diagnostics. Prominent trends identified for this period encompass the growing acceptance of targeted therapies and immunotherapy, a surge in the application of advanced ocular imaging technologies, an intensified emphasis on detecting tumors early, the development of more personalized treatment plans, and improved incorporation of multidisciplinary approaches in eye care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21312&type=smp

Which Primary Drivers Are Impacting The Uveal Neoplasms Market Growth?

The increasing occurrence of eye cancer is anticipated to drive the expansion of the uveal neoplasms market in the future. Eye cancer is defined as the uncontrolled proliferation of atypical cells within the eye, potentially affecting different ocular structures like the retina, iris, or optic nerve. This increase in eye cancer cases can be linked to elements such as enhanced diagnostic capabilities, exposure to environmental factors, and an aging demographic. Uveal neoplasms, especially uveal melanoma, represent an uncommon type of eye cancer capable of spreading to other organs, most significantly the liver, thereby presenting substantial health hazards. As an example, in 2023, data from Cancer Research UK, a UK-based cancer research organization, indicates that eye cancer incidence rates are forecasted to increase by 50% in the UK between 2023-2025 and 2038-2040, reaching an average of 3 cases per 100,000 people annually by 2038. Consequently, the growing occurrence of eye cancer is propelling the development of the uveal neoplasms market.

Which Segment Classifications Are Used In The Uveal Neoplasms Market Segment Analysis?

The uveal neoplasms market covered in this report is segmented –

1) By Treatment Type: Drugs, Therapy

2) By Route Of Administration: Oral, Injectable, Other Route Administration

3) By Distribution Channel: Hospitals Pharmacies, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Drugs: Chemotherapeutic Agents, Targeted Therapy Drugs, Immunotherapy Drugs

2) By Therapy: Radiation Therapy, Laser Therapy, Photodynamic Therapy

Which Trends Are Shaping Growth In The Uveal Neoplasms Market?

Major companies operating in the uveal neoplasms market are increasingly adopting advanced liver-directed treatment approaches, such as percutaneous hepatic perfusion (PHP), to enhance localized tumor control and reduce systemic toxicity. Percutaneous hepatic perfusion (PHP) is a minimally invasive technique that isolates the liver’s blood supply to deliver high-dose chemotherapy directly into the hepatic artery, while filtering the blood exiting the liver. This method facilitates concentrated treatment at the tumor site with reduced exposure to the rest of the body. For instance, in August 2023, Delcath Systems, Inc., a US-based interventional oncology company, received U.S. Food and Drug Administration (FDA) approval for HEPZATO KIT. This PHP-based therapy is designed for treating metastatic uveal melanoma with unresectable liver-dominant metastases, featuring targeted melphalan infusion and extracorporeal filtration of hepatic blood, with treatment cycles typically repeated every 6–8 weeks as clinically appropriate. HEPZATO KIT enables higher local drug concentration with reduced systemic exposure and has demonstrated clinically meaningful benefits, including tumor response and disease control in eligible metastatic uveal melanoma patients.

Which Firms Are Contributing To The Uveal Neoplasms Market Ecosystem?

Major companies operating in the uveal neoplasms market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., IDEAYA Biosciences Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Verastem Oncology Inc., Iovance Biotherapeutics Inc., Immunocore Holdings PLC, Aura Biosciences, Foghorn Therapeutics Inc., Syncona Limited, iOnctura SA, Linnaeus Therapeutics, Inc., Delcath Systems Inc, Bellicum Pharmaceuticals Inc.

Get The Full Uveal Neoplasms Market Report:

https://www.thebusinessresearchcompany.com/report/uveal-neoplasms-global-market-report

Where Is The Uveal Neoplasms Market Primarily Concentrated By Region?

North America was the largest region in the uveal neoplasms market in 2025. The regions covered in the uveal neoplasms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Uveal Neoplasms Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/uveal-neoplasms-global-market-report

Browse Through More Reports Similar to the Global Uveal Neoplasms Market 2026, By The Business Research Company

Transdermal Skin Patche Market Report 2026

https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report

Retinitis Pigmentosa Market Report

https://www.thebusinessresearchcompany.com/report/retinitis-pigmentosa-global-market-report

Skin Cancer Diagnostics Market Report

https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795